Diagnosis of Avascular Necrosis of the Femoral-Head in Patients Treated for Lymphoma

M A Ratcliffe, Fiona Jane Gilbert, A A Dawson, B Bennett

Research output: Contribution to journalArticlepeer-review

11 Citations (Scopus)


Avascular necrosis of bone (AVNB) is a well-known but rare complication of chemotherapy for lymphoma with a reported incidence ranging from 1 to 10 per cent. Early diagnosis is essential for optimal therapeutic management. Using MRI, the most sensitive means of detecting the earlier stages of AVNB, 100 patients treated with standard chemotherapy for lymphoma were assessed. Fifteen were found to have changes of AVNB, 10 with early changes but five with advanced segmental collapse of the femoral head. None with AVNB had more than the standard course of corticosteroids.

Almost a quarter of the study group complained of joint pain during and/or after their treatment, a third of whom were found to have AVNB; a strong indicator to screen all those with pain. However, 40 per cent of those with AVNB were asymptomatic. The clinical significance of the 'silent hip' is yet to be elucidated.

Original languageEnglish
Pages (from-to)131-137
Number of pages7
JournalHematological Oncology
Issue number3
Publication statusPublished - May 1995


  • PAIN
  • BONE
  • HIP
  • Lymphoma
  • Avascular necrosis
  • Pain
  • Corticosteroids
  • Hodgkinsons Disease
  • Osteonecrosis
  • Bone
  • Hip


Dive into the research topics of 'Diagnosis of Avascular Necrosis of the Femoral-Head in Patients Treated for Lymphoma'. Together they form a unique fingerprint.

Cite this